On April 19, 2022 Nykode Therapeutics AS (Euronext Growth (Oslo): NYKD), a clinicalstage biopharmaceutical company dedicated to the discovery and development of vaccines and novel immunotherapies, reported that it will host a Capital Markets Day for investors and analysts on May 12, 2022 from 2 p.m. CET / 8 a.m. ET (Press release, Nykode Therapeutics, APR 19, 2022, View Source [SID1234612490]). The event will be hosted both with the possibility for physical attendance at Nykode’s facilities in Oslo, Norway, as well as a live webcast. The Capital Markets Day will feature updates on Nykode’s business, innovations and latest developments.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Further details of the agenda and registration details will follow.